• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.79% Nasdaq Up0.53%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    9.84 Down 0.14(1.40%) Jul 1, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 1,175   569   256   -  
    Cost of Revenue528  341  154   -  
    Gross Profit 647   228   102   -  
    Operating Expenses
    Research Development9,591  5,815  19,053  10,275  
    Selling General and Administrative18,880  34,050  16,447  12,268  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (27,824) (39,637) (35,398) (22,543)
    Income from Continuing Operations
    Total Other Income/Expenses Net107  52  109  129  
    Earnings Before Interest And Taxes(27,717)(39,585)(35,289)(22,414)
    Interest Expense -   -   -   -  
    Income Before Tax(27,717)(39,585)(35,289)(22,414)
    Income Tax Expense22  700   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(27,739)(40,285)(35,289)(22,414)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (27,739) (40,285) (35,289) (22,414)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (27,739) (40,285) (35,289) (22,414)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.